Seeing Is Believing

Currently out of the existing stock ratings of Mohan Naidu, 67 are a BUY (97.1%), 2 are a HOLD (2.9%).
Analyst Mohan Naidu, carries an average stock price target met ratio of 81.15% that have a potential upside of 30.94% achieved within 578 days.
Mohan Naidu’s has documented 151 price targets and ratings displayed on 12 stocks. The coverage was on Healthcare, Technology sectors.
Most recent stock forecast was given on EVH, Evolent Health at 23-Jan-2025.
Analyst best performing recommendations are on TRHC (TABULA RASA HEALTHCARE).
The best stock recommendation documented was for TDOC (TELADOC) at 1/24/2025. The price target of $12 was fulfilled within 14 days with a profit of $1.91 (18.93%) receiving and performance score of 13.52.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy
$120
$23.5 (24.35%)
$100
21 days ago
(07-Oct-2025)
7/8 (87.5%)
$27.91 (30.31%)
408
Buy
$126
$29.5 (30.57%)
$125
1 months 26 days ago
(02-Sep-2025)
7/10 (70%)
$30.46 (31.88%)
133
Buy
$125
$28.5 (29.53%)
$125
1 months 26 days ago
(02-Sep-2025)
21/25 (84%)
$29.46 (30.84%)
176
Buy
$134
$37.5 (38.86%)
$130
1 months 26 days ago
(02-Sep-2025)
9/11 (81.82%)
$38.46 (40.26%)
396
Buy
$115
$18.5 (19.17%)
$103
4 months 24 days ago
(04-Jun-2025)
17/18 (94.44%)
$2.3 (2.04%)
198
What Year was the first public recommendation made by Mohan Naidu?